In conclusion, we show that pharmacological inhibition or genetic ablation of PI3K/AKT during REP stage of TIL in cervical and ovarian cancer promotes the propagation of tumor‐reactive TIL with memory‐like phenotype. The gene discussed is PIK3CD; the disease is ovarian cancer.